Analyses of Patients with Locally Advanced-Stage HNSCC Receiving Everolimus as Adjuvant Therapy
Physician's Weekly,
The following is a summary of “A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients…
A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck
Overview of attention for article published in Clinical Cancer Research, October 2022
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (90th percentile)
-
Good Attention Score compared to outputs of the same age and source (66th percentile)
Readers on
- mendeley
- 14 Mendeley